Quanterix Corporation Operating Income
Quanterix Corporation (QTRX) reported Operating Income of -$49.43 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-10
- Quanterix Corporation operating income (loss) for the quarter ending 2026-06-30 was -$49.43M.
- Quanterix Corporation operating income (loss) for the quarter ending 2026-03-31 was -$41.36M.
- Quanterix Corporation operating income (loss) for the quarter ending 2025-12-31 was -$24.75M.
- Quanterix Corporation operating income (loss) for the quarter ending 2025-09-30 was -$37.33M.
- Quanterix Corporation operating income (loss) for fiscal 2025 was -$125.54M.
- Quanterix Corporation operating income (loss) for fiscal 2024 was -$52.62M.
- Quanterix Corporation operating income (loss) for fiscal 2023 was -$45.99M.
- Quanterix Corporation operating income (loss) for fiscal 2022 was -$104.26M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$49.43M 10-Q · filed 2026-08-10 | -$90.79M 10-Q · filed 2026-08-10 | -$115.54M derived: sum of 3 quarters · filed 2026-08-10 | -$152.87M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2026-03-31 | -$41.36M 10-Q · filed 2026-05-06 | -$66.11M derived: sum of 2 quarters · filed 2026-05-06 | -$103.44M derived: sum of 3 quarters · filed 2026-05-06 | -$140.54M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-12-31 | -$24.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$62.08M derived: sum of 2 quarters · filed 2026-03-02 | -$99.18M derived: sum of 3 quarters · filed 2026-08-10 | -$125.54M 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | -$37.33M 10-Q · filed 2025-11-10 | -$74.42M derived: sum of 2 quarters · filed 2026-08-10 | -$100.79M 10-Q · filed 2025-11-10 | -$115.56M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-06-30 | -$37.10M 10-Q · filed 2026-08-10 | -$63.47M 10-Q · filed 2026-08-10 | -$78.23M derived: sum of 3 quarters · filed 2026-08-10 | -$89.98M derived: sum of 4 quarters · filed 2026-08-10 | ||||
| 2025-03-31 | -$26.37M 10-Q · filed 2026-05-06 | -$41.13M derived: sum of 2 quarters · filed 2026-05-06 | -$52.88M derived: sum of 3 quarters · filed 2026-05-06 | -$63.83M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$14.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$26.52M derived: sum of 2 quarters · filed 2026-03-02 | -$37.46M derived: sum of 3 quarters · filed 2026-03-02 | -$52.62M 10-K · filed 2026-03-02 | ||||
| 2024-09-30 | -$11.75M 10-Q · filed 2025-11-10 | -$22.69M derived: sum of 2 quarters · filed 2025-11-10 | -$37.85M 10-Q · filed 2025-11-10 | -$51.46M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | -$10.94M 10-Q · filed 2025-08-07 | -$13.11M 10-Q · filed 2024-08-08 | -$26.10M 10-Q · filed 2025-08-07 | -$27.07M 10-Q · filed 2024-08-08 | -$39.72M derived: sum of 3 quarters · filed 2025-08-07 | -$52.52M derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | -$15.16M 10-Q · filed 2025-05-12 | -$13.97M 10-Q · filed 2024-05-08 | -$28.77M derived: sum of 2 quarters · filed 2025-05-12 | -$41.58M derived: sum of 3 quarters · filed 2025-05-12 | -$50.57M derived: sum of 4 quarters · filed 2025-05-12 | |||
| 2023-12-31 | -$13.62M 10-K/A · filed 2024-12-26 | -$26.43M derived: sum of 2 quarters · filed 2024-12-26 | -$35.41M derived: sum of 3 quarters · filed 2024-12-26 | -$45.99M 10-K · filed 2026-03-02 | -$49.70M 10-K · filed 2024-02-29 | |||
| 2023-09-30 | -$12.81M 10-K/A · filed 2024-12-26 | -$13.77M 10-Q · filed 2023-11-08 | -$21.80M derived: sum of 2 quarters · filed 2024-12-26 | -$32.37M 10-K/A · filed 2024-12-26 | -$32.75M 10-Q · filed 2023-11-08 | -$53.77M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2023-06-30 | -$8.99M 10-K/A · filed 2024-12-26 | -$9.56M 10-Q · filed 2023-08-08 | -$19.57M 10-K/A · filed 2024-12-26 | -$18.98M 10-Q · filed 2023-08-08 | -$40.96M derived: sum of 3 quarters · filed 2024-12-26 | -$78.91M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2023-03-31 | -$10.58M 10-K/A · filed 2024-12-26 | -$9.42M 10-Q · filed 2023-05-09 | -$31.97M derived: sum of 2 quarters · filed 2024-12-26 | -$69.92M derived: sum of 3 quarters · filed 2024-12-26 | -$96.89M derived: sum of 4 quarters · filed 2024-12-26 | |||
| 2022-12-31 | -$21.39M 10-K/A · filed 2024-12-26 | -$59.35M derived: sum of 2 quarters · filed 2024-12-26 | -$86.31M derived: sum of 3 quarters · filed 2024-12-26 | -$104.26M 10-K · filed 2025-03-17 | -$101.70M 10-K · filed 2023-03-06 | |||
| 2022-09-30 | -$37.95M 10-K/A · filed 2024-12-26 | -$36.60M 10-Q · filed 2022-11-09 | -$64.92M derived: sum of 2 quarters · filed 2024-12-26 | -$82.87M 10-K/A · filed 2024-12-26 | -$79.75M 10-Q · filed 2022-11-09 | -$100.70M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2022-06-30 | -$26.96M 10-K/A · filed 2024-12-26 | -$24.96M 10-Q · filed 2022-08-08 | -$44.92M 10-K/A · filed 2024-12-26 | -$43.15M 10-Q · filed 2022-08-08 | -$62.75M derived: sum of 3 quarters · filed 2024-12-26 | -$77.98M derived: sum of 4 quarters · filed 2024-12-26 | ||
| 2022-03-31 | -$17.95M 10-K/A · filed 2024-12-26 | -$18.19M 10-Q · filed 2022-05-10 | -$35.78M derived: sum of 2 quarters · filed 2024-12-26 | -$51.02M derived: sum of 3 quarters · filed 2024-12-26 | -$64.69M derived: sum of 4 quarters · filed 2024-12-26 | |||
| 2021-12-31 | -$17.83M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-12-26 | -$33.06M derived: sum of 2 quarters · filed 2024-12-26 | -$46.73M derived: sum of 3 quarters · filed 2024-12-26 | -$56.52M 10-K/A · filed 2024-12-26 | -$58.59M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | -$15.23M 10-Q · filed 2022-11-09 | -$28.90M derived: sum of 2 quarters · filed 2022-11-09 | -$38.69M 10-Q · filed 2022-11-09 | -$48.62M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$13.67M 10-Q · filed 2022-08-08 | -$23.46M 10-Q · filed 2022-08-08 | -$33.39M derived: sum of 3 quarters · filed 2022-08-08 | -$31.11M derived: sum of 4 quarters · filed 2022-08-08 | ||||
| 2021-03-31 | -$9.79M 10-Q · filed 2022-05-10 | -$19.72M derived: sum of 2 quarters · filed 2022-05-10 | -$17.44M derived: sum of 3 quarters · filed 2022-05-10 | -$29.64M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | -$9.93M 10-K · filed 2021-03-05 | -$7.66M derived: sum of 2 quarters · filed 2021-11-04 | -$19.86M derived: sum of 3 quarters · filed 2021-11-04 | -$31.58M 10-K · filed 2023-03-06 | ||||
| 2020-09-30 | $2.28M 10-Q · filed 2021-11-04 | -$9.92M derived: sum of 2 quarters · filed 2021-11-04 | -$21.65M 10-Q · filed 2021-11-04 | -$33.14M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | -$12.20M 10-Q · filed 2021-08-05 | -$23.93M 10-Q · filed 2021-08-05 | -$35.41M derived: sum of 3 quarters · filed 2021-08-05 | -$45.66M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | -$11.73M 10-Q · filed 2021-05-06 | -$23.21M derived: sum of 2 quarters · filed 2021-05-06 | -$33.46M derived: sum of 3 quarters · filed 2021-05-06 | -$43.97M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | -$11.49M 10-K · filed 2021-03-05 | -$21.73M derived: sum of 2 quarters · filed 2021-03-05 | -$32.24M derived: sum of 3 quarters · filed 2021-03-05 | -$41.60M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | -$10.24M 10-K · filed 2021-03-05 | -$20.76M derived: sum of 2 quarters · filed 2021-03-05 | -$30.12M 10-Q · filed 2020-11-06 | -$39.53M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2019-06-30 | -$10.51M 10-K · filed 2021-03-05 | -$19.87M 10-Q · filed 2020-08-04 | -$29.29M derived: sum of 3 quarters · filed 2021-03-05 | -$36.95M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2019-03-31 | -$9.36M 10-K · filed 2021-03-05 | -$18.77M derived: sum of 2 quarters · filed 2021-03-05 | -$26.43M derived: sum of 3 quarters · filed 2021-03-05 | -$33.74M derived: sum of 4 quarters · filed 2021-03-05 | ||||
| 2018-12-31 | -$9.41M 10-K · filed 2020-03-13 | -$17.08M derived: sum of 2 quarters · filed 2020-03-13 | -$24.39M derived: sum of 3 quarters · filed 2020-03-13 | -$31.55M 10-K · filed 2021-03-05 | ||||
| 2018-09-30 | -$7.66M 10-K · filed 2020-03-13 | -$14.97M derived: sum of 2 quarters · filed 2020-03-13 | -$22.14M 10-Q · filed 2019-11-08 | -$29.23M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2018-06-30 | -$7.31M 10-K · filed 2020-03-13 | -$14.47M 10-Q · filed 2019-08-06 | -$21.57M derived: sum of 3 quarters · filed 2020-03-13 | -$27.95M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2018-03-31 | -$7.16M 10-K · filed 2020-03-13 | -$14.26M derived: sum of 2 quarters · filed 2020-03-13 | -$20.64M derived: sum of 3 quarters · filed 2020-03-13 | -$27.11M derived: sum of 4 quarters · filed 2020-03-13 | ||||
| 2017-12-31 | -$7.09M 10-K · filed 2019-03-18 | -$13.48M derived: sum of 2 quarters · filed 2019-03-18 | -$19.95M derived: sum of 3 quarters · filed 2019-03-18 | -$26.00M 10-K · filed 2020-03-13 | ||||
| 2017-09-30 | -$6.39M 10-K · filed 2019-03-18 | -$12.86M derived: sum of 2 quarters · filed 2019-03-18 | -$18.91M 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | -$6.47M 10-K · filed 2019-03-18 | -$12.53M 10-Q · filed 2018-08-10 | ||||||
| 2017-03-31 | -$6.06M 10-K · filed 2019-03-18 | |||||||
| 2016-12-31 | -$21.71M 10-K · filed 2019-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |